Dental implants provide an effective method for replacing missing teeth, though their success rates can vary considerably among immunocompromised patients. This study focuses on evaluating implant outcomes in individuals with systemic conditions such as diabetes mellitus, HIV/AIDS, and autoimmune disorders, examining their effects on osseointegration and complications like peri-implantitis. Over a five-year period, a retrospective cohort of 400 patients—comprising 200 immunocompromised individuals and 200 healthy controls—was reviewed. Key metrics, including implant survival, peri-implant bone loss, and associated complications, were analysed. Findings showed that immunocompromised patients had a markedly lower survival rate of 81% compared to 96% in the control group. Potential strategies to enhance outcomes in this population are also explored.
Keywords: Dental implants, Implant survival rate, Immunocompromised patients, Osseointegration.